One front. One fight in confronting antimicrobial resistance (AMR): find out how to tackle the AMR threat in this video, produced by BBC StoryWorks Commercial Productions, as part of a series presented by MedTech Europe.

In this episode of BBC StoryWorks Commercial Productions "Connecting the Dots" we explain how Sorbact® Technology dressings bind, inhibit and remove bacteria without the release of active substances and that they can be a powerful tool for healthcare professionals to combat AMR.

At Essity®, we recognize the importance of tackling AMR and address the growing concern of the “silent pandemic”.

The global threat of AMR is growing, and fast. The World Health Organization (WHO) estimates that the death toll due to drug-resistant bacteria could reach 10 million a year by 2050.2, 3

We invite you to join us and take a closer look at how Sorbact® Technology dressings can help support our collective effort against AMR.

At least 30% of antibiotics prescribed in

the outpatient setting are unnecessary.1

Antimicrobial resistance (AMR) stems from the frequent and particularly inappropriate use of antibiotics to treat infections. Bacteria and fungi adapt, rendering antimicrobials ineffective, permitting their unchecked growth.

30 Percent

Use Sorbact® Technology dressings to combat AMR

  • Effectively prevents and treats wound infections.4, 5
  • Reduces bioburden6 without antimicrobial agents and may lower the use of antibiotics.7, 8
  • Bacterial and fungal resistance is not expected to occur from the binding of microorganisms.

Want to find out more about the products based on Sorbact® Technology?

Always follow the directions for use.

READ MORE HERE

How does Sorbact® Technology work

Bind Img
Inhibit
Remove Img
LEARN MORE HERE

Your Role in the Effort Against AMR

Effectively tackling AMR requires collective effort.

Whether you're a surgeon, nurse, doctor, pharmacist,

or cargiver:

+ Keep your hands and instruments clean. +

+ Report resistant infections to designated teams. +

+ Educate patients about antibiotics and infections. +

+ Only prescribe and dispense antibiotics when needed. +

Do you want to find out more about tackling antimicrobial resistance?

Tackling Antimicrobial Resistance Image
DOWNLOAD WHITE PAPER

All references

  1. Fleming-Dutra KE et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016;315(17):1864-1873.
  2. World Health Organization, Global Action Plan on Antimicrobial Resistance, May 2015.
  3. O’Neill J. Tackling drug-resistant infections globally: Final Report and Recommendations. The Review on Antimicrobial Resistance. 2016.
  4. Stanirowski PJ et al., Randomized Controlled Trial Evaluating Dialkylcarbamoyl Chloride Impregnated Dressings for the Prevention of Surgical Site Infections in Adult Women Undergoing Cesarean Section. Surg Infect (Larchmt). 2016;17(4):427-435.
  5. Ciprandi et al., Meeting the Challenges in Pediatric Wound Care: Our 15-Year Experience with Dialkylcarbamoyl Chloride-Coated Dressing Technology in Acute and Chronic Wounds. Chronic Wound Care Management and Research. 2022;9:23-33.
  6. Ciliberti M et al., The Effect of a Bacteria- and Fungi-binding Mesh Dressing on the Bacterial Load of Pressure Ulcers Treated with Negative Pressure Wound Therapy: A Pilot Study. Wounds. 2016;28(11):408-420.
  7. Williams K., The Leeds Wound Infection Framework: Development and implementation of a new pathway to improve care. Wounds UK. 2022;18(1):6-110.
  8. Stanirowski PJ et al., Dialkylcarbamoyl chloride-impregnated dressing for the prevention of surgical site infection in women undergoing cesarean section: a pilot study. Arch Med Sci. 2016;12(5):1036-1042.

Contact Information

Essity (T/A BSN medical Aust. Pty Ltd)
PO Box 337
Mount Waverley, Victoria, 3149
Australia
 

Australia:
customerservice.AU@essity.com
T: 1300 276 633 F: 1300 998 830
 
New Zealand:
customerservice.NZ@essity.com
T: 0508 276 111 F: 0508 998 830